Composition and method for stabilizing fluorescent particles
Embodiments of a composition for stabilizing fluorescent signal of nanoparticles and methods for its use are disclosed. In some embodiments, the composition has a pH from 7 to 10 and includes borate, protein and/or protein hydrolysate, an amine, a preservative, and a nonionic surfactant. In particular embodiments, the amine is an N-ethanol substituted amine, such as ethanolamine, diethanolamine, triethanolamine, N-methyldiethanolamine, N,N-dimethylethanolamine, or a combination thereof. In some embodiments, a fluorescent particle solution, such as a quantum dot solution or quantum dot conjugate solution, is diluted in the composition and stored at 4° C. In certain embodiments, the fluorescence intensity of the diluted fluorescent particle remains substantially the same when stored at 4° C. for at least one month or at least three months. In particular embodiments, a diluted quantum dot conjugate is used to detect a hybridized probe or a protein antigen.
1. A composition for stabilizing a quantum dot fluorescent particle or a quantum dot conjugate fluorescent particle, the composition having a pH greater than or equal to 7, the composition comprising:
(a) (i) a substituted amine, other than an amino acid or an alkyl-substituted alkyl amine, the substituted amine having a formula R n NH (3-n) , where n=1, 2, or 3, each R is independently an aliphatic group, a heteroaliphatic group, an aryl group, a heteroaryl group, an alkyl aryl group, or an aryl alkyl group, and at least one R is substituted with one or more —OH, —OR 1 , —CO 2 R 1 , —CN groups, or combinations thereof, where R 1 is a substituted or unsubstituted aliphatic or aryl group, or (ii) an amine and a protein and/or protein hydrolysate, wherein at least one of the substituted amine, the amine, or the protein and/or protein hydrolysate is present at a concentration effective to stabilize and/or increase fluorescence intensity of a fluorescent particle stored in the composition relative to fluorescence intensity of the fluorescent particle stored in a composition devoid of (i) a substituted amine other than an amino acid or an alkyl-substituted alkyl amine, or (ii) an amine and a protein and/or protein hydrolysate;
(b) a borate buffer comprising a salt concentration of from greater than zero to 2 M;
(c) a preservative; and
(d) a surfactant.
2. The composition of claim 1 , comprising:
0.02 M to 0.5 M borate;
0.05 wt % to 1.5 wt % protein and/or protein hydrolysate;
25 mM to 200 mM amine;
0.05 wt % to 0.2 wt % preservative; and
0.005 wt % to 0.05 wt % surfactant.
3. The composition of claim 1 , where the amine is a substituted amine having the formula R n NH (3-n) , where n=1, 2, or 3, each R is independently an aliphatic group, a heteroaliphatic group, an aryl group, a heteroaryl group, an alkyl aryl group, or an aryl alkyl group, and at least one R is substituted.
4. The composition of claim 3 , where at least one R is substituted with one or more —OH, —OR 1 , —CO 2 R 1 , —CN groups, or combinations thereof, where R 1 is a substituted or unsubstituted aliphatic or aryl group.
5. The composition of claim 1 , where the amine comprises an N-ethanol substituted amine.
6. The composition of claim 1 , where the amine is ethanolamine, diethanolamine, triethanolamine, N-methyldiethanolamine, N,N-dimethylethanolamine, or a combination thereof.
7. The composition of claim 1 , where the protein and/or protein hydrolysate is vegetable tryptone, salmon peptone, chicken albumin hydrolysates, casein hydrolysates, gelatin from fish skin, or a combination thereof.
8. The composition of claim 1 , where the preservative is sodium azide, a preservative composition comprising 9.5-9.9% 2-methyl-4-isothiazolin-3-one, a preservative composition comprising 2.3% 5-chloro-2-methyl-4-isothiazolin-3-one, 0.7-% 2-methyl-4-isothiazolin-3-one, 2-3% alkyl carboxylate, 93-95% modified glycol, or a combination thereof.
9. The composition of claim 1 , where the surfactant is a nonionic surfactant.
10. The composition of claim 9 , where the surfactant is polyethylene glycol sorbitan monolaurate, polyethylene glycol p-(1,1,3,3-tetramethylbutyl)-phenyl ether), or polyoxyethyleneglycol dodecyl ether.
11. The composition of claim 1 , where the composition has a pH of 7 to 9.
12. The composition of claim 1 , further comprising a fluorescent particle selected from a quantum dot fluorescent particle or a quantum dot conjugate fluorescent particle, wherein fluorescence intensity of the fluorescent particle is increased relative to fluorescence intensity of the fluorescent particle in a composition devoid of (i) a substituted amine other than an amino acid or an alkyl-substituted alkyl amine, or (ii) an amine and a protein and/or protein hydrolysate.
13. The composition of claim 12 , where fluorescence intensity, at a time subsequent to mixing the fluorescent particle with the composition, is increased at least 5% relative to fluorescence intensity of the fluorescent particle in a composition devoid of (i) a substituted amine other than an amino acid or an alkyl-substituted alkyl amine, or (ii) an amine and a protein and/or protein hydrolysate.
14. A composition for stabilizing a quantum dot fluorescent particle or a quantum dot conjugate fluorescent particle, the composition comprising:
a quantum dot fluorescent particle or a quantum dot conjugate fluorescent particle;
0.3 M borate;
1 wt % casein hydrolysates;
50 mM triethanolamine;
0.08 wt % sodium azide; and
0.005 wt % polyethylene glycol sorbitan monolaurate, wherein the composition has a pH of 8 to 8.5;
wherein fluorescence intensity of the quantum dot fluorescent particle or quantum dot conjugate fluorescent particle is increased relative to fluorescence intensity of the fluorescent particle in a composition devoid of (i) a substituted amine other than an amino acid or an alkyl-substituted alkyl amine, or (ii) an amine and a protein and/or protein hydrolysate.
15. A method, comprising:
providing a fluorescent particle solution comprising at least one quantum dot fluorescent particle or quantum dot conjugate fluorescent particle; and
diluting the fluorescent particle solution in a composition to provide a diluted fluorescent particle solution, the composition having a pH greater than or equal to 7 and comprising (a) (i) a substituted amine, other than an amino acid or an alkyl-substituted alkyl amine, the substituted amine having the formula R n NH (3-n) , where n=1, 2, or 3, each R is independently an aliphatic group, a heteroaliphatic group, an aryl group, a heteroaryl group, an alkyl aryl group, or an aryl alkyl group, and at least one R is substituted with one or more —OH, —OR 1 , —CO 2 R 1 , —CN groups, or combinations thereof, where R 1 is a substituted or unsubstituted aliphatic or aryl group, or (ii) an amine and a protein and/or protein hydrolysate, wherein at least one of the substituted amine, the amine or the protein and/or protein hydrolysate is present at a concentration effective to stabilize and/or increase fluorescence of the fluorescent particle; (b) a borate buffer comprising a salt concentration of from greater than zero to 2 M; (c) a preservative; and (d) a surfactant.
16. The method of claim 15 , where fluorescence intensity of the diluted fluorescent particle solution, at a time subsequent to diluting the fluorescent particle solution in the composition, is increased at least 5% relative to fluorescence intensity of a diluted fluorescent particle solution formed by diluting the fluorescent particle solution in a composition devoid of a substituted amine other than an amino acid or an alkyl-substituted alkyl amine, or an amine and a protein and/or protein hydrolysate.
17. The method of claim 15 , where the composition comprises 0.05 M to 0.5 M borate, 0.05 wt % to 1.1 wt % protein and/or protein hydrolysate, 50 mM to 100 mM amine, 0.05 wt % to 0.2 wt % preservative, and 0.005 wt % to 0.05 wt % nonionic surfactant.
18. The method of claim 15 , further comprising storing the diluted fluorescent particle solution at 4° C.
19. The method of claim 18 , where fluorescence intensity of the diluted fluorescent particle solution remains substantially the same after storage at 4° C. for one month.
20. The method of claim 15 , where the fluorescent particle solution is a quantum dot conjugate solution comprising at least one quantum dot conjugate, and the quantum dot conjugate solution is diluted to a concentration of 0.5 nM to 150 nM to provide a diluted quantum dot conjugate solution.
21. The method of claim 15 , further comprising using the diluted fluorescent particle solution to detect a probe hybridized to a target or to detect a protein antigen on a tissue sample, wherein the fluorescent particle is a quantum dot-antibody conjugate capable of specifically interacting with the probe or with the protein antigen,
wherein the composition has a pH greater than or equal to 7, and
wherein fluorescence intensity of the quantum dot-antibody conjugate is increased relative to fluorescence intensity of the quantum dot-antibody conjugate in a composition devoid of a substituted amine other than an amino acid or an alkyl-substituted amine, or an amine and a protein and/or protein hydrolysate.
22. The method of claim 21 , where the fluorescent particle solution is diluted to provide a diluted fluorescent particle solution comprising 5 nM to 100 nM quantum dot-antibody conjugate, 0.05 M to 0.5 M borate, 0.05 wt % to 1.1 wt % protein and/or protein hydrolysate, 50 mM to 100 mM N-ethanol substituted amine, 0.05 wt % to 0.1 wt % sodium azide, and 0.005 wt % to 0.05 wt % nonionic surfactant and having a pH of 8-9.
23. The method of claim 22 where the diluted fluorescent particle solution has a pH in the range of 8 to 8.5 and comprises 5 nM to 100 nM quantum dot-antibody conjugate, 0.32 M borate, 1.0 wt % casein hydrolysates, 50 mM triethanolamine, 0.08 wt % sodium azide, and 0.005 wt % polyethylene glycol sorbitan monolaurate.
24. A composition for stabilizing a quantum dot fluorescent particle or a quantum dot conjugate fluorescent particle, the composition comprising:
(a) an alkyl amine wherein one or more alkyl groups are substituted with one or more —OH, —CO 2 R 1 , —CN groups, or combinations thereof, where R 1 is a substituted or unsubstituted aliphatic or aryl group;
(b) a protein and/or protein hydrolysate selected from vegetable tryptone, salmon peptone, chicken albumin hydrolysates, casein hydrolysates, gelatin from fish skin, or a combination thereof;
(c) a borate buffer comprising a salt concentration of from greater than zero to 2 M;
(d) a preservative selected from an isothiazolinone, a glycol, an azide, or a combination thereof; and
(e) a glycol surfactant.
25. The composition of claim 24 , wherein:
the alkyl amine is selected from ethanolamine, diethanolamine, triethanolamine, N-methyldiethanolamine, or N,N-dimethylethanolamine;
the protein and/or protein hydrolysate is selected from vegetable tryptone, salmon peptone, chicken albumin hydrolysates, casein hydrolysates, gelatin from fish skin, or a combination thereof;
the preservative is an azide preservative; and
the glycol surfactant is selected from polyethylene glycol sorbitan monolaurate, polyethylene glycol p-(1,1,3,3-tetramethylbutyl)-phenyl ether), polyoxyethyleneglycol dodecyl ether, or a combination thereof.
26. The composition of claim 25 , comprising:
0.02 M to 0.5 M borate buffer;
0.5 wt % to 1.1 wt % protein and/or protein hydrolysate;
38 mM to 75 mM alkyl amine;
0.05 wt % to 0.1 wt % azide preservative; and
0.005 wt % to 0.01 wt % glycol surfactant.